{
    "clinical_study": {
        "@rank": "78779", 
        "arm_group": [
            {
                "arm_group_label": "highest dose Paracetamol + caffeine", 
                "arm_group_type": "Active Comparator", 
                "description": "highest dose of Paracetamol and caffeine"
            }, 
            {
                "arm_group_label": "low-dose Paracetamol + caffeine", 
                "arm_group_type": "Active Comparator", 
                "description": "lowest dose of Paracetamol and caffeine"
            }, 
            {
                "arm_group_label": "high dose paracetamol", 
                "arm_group_type": "Active Comparator", 
                "description": "highest dose paracetamol"
            }, 
            {
                "arm_group_label": "low dose paracetamol", 
                "arm_group_type": "Active Comparator", 
                "description": "lowest dose paracetamol"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will investigate any improvement in alertness and performance based on cognitive\n      function and mood assessment in subjects suffering the common cold, when taking a novel\n      paracetamol and caffeine combination verses paracetamol alone."
        }, 
        "brief_title": "Effects of Two Doses of a Common Cold Treatment on Alertness", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Common Cold", 
        "condition_browse": {
            "mesh_term": "Common Cold"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Participants with symptoms of cold < 96 hours, rating of at least '2' on malaise at\n             least 4 other symptoms of cold.\n\n          -  No history of clinically significant perennial rhinitis, no recent antibiotic,\n             antihistamine or cold treatment, no caffeine in the previous 12 hours, no\n             psychoactive medication in the 14 days prior to screening, no pregnancy,\n             breastfeeding or participation in this trial, or another trial in the 30 days prior\n             to screening."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01686646", 
            "org_study_id": "RH01361"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "highest dose Paracetamol + caffeine", 
                    "low-dose Paracetamol + caffeine"
                ], 
                "description": "paracetamol with caffeine", 
                "intervention_name": "paracetamol + caffeine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "high dose paracetamol", 
                    "low dose paracetamol"
                ], 
                "description": "paracetamol", 
                "intervention_name": "paracetamol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Acetaminophen", 
                "Caffeine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "alertness", 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cardiff", 
                    "country": "United Kingdom", 
                    "state": "Wales"
                }, 
                "name": "Common Cold Centre"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effects of Two Doses of a Common Cold Treatment on Cognitive Function", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.", 
            "measure": "Change from baseline in number of accurate responses to Rapid Visual Information Processing (RVIP) Cognitive test", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 60 minutes post treatment administration"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01686646"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.", 
                "measure": "Change from baseline in number of accurate responses to RVIP Cognitive test", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 120 minutes post treatment administration"
            }, 
            {
                "description": "The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. Mean reaction time was determined.", 
                "measure": "Change from baseline in mean time of accurate responses to RVIP Cognitive Task", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 60 minutes and upto 120 minutes post treatment administration"
            }, 
            {
                "description": "The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and mean number of valid responses to stimulus was calculated.", 
                "measure": "Change from baseline in number of inaccurate and missed responses to RVIP Cognitive Task", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 60 minutes and up to 120 minutes post treatment administration"
            }, 
            {
                "description": "Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Mean values of accurate responses to visual and auditory tests were calculated.", 
                "measure": "Change from baseline in number of accurate responses to Sustained Attention Tasks (SAT) Cognitive test", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 60 minutes and up to 120 minutes post treatment administration"
            }, 
            {
                "description": "Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Mean values of valid reaction time to visual and auditory tests were calculated.", 
                "measure": "Change from baseline in mean time of accurate responses to SAT Cognitive Task", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 30 minutes and up to 60 minutes post treatment administration"
            }, 
            {
                "description": "Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Mean values of incorrect and missed responses to visual and auditory tests were calculated.", 
                "measure": "Change from baseline in number of incorrect and missed responses to SAT Cognitive test", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 60 minutes and up to 120 minutes post treatment administration"
            }, 
            {
                "description": "For the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Mean values of accurate responses to visual and auditory tests were calculated.", 
                "measure": "Change from baseline in number of valid responses to Divided Attention Task (DAT) Cognitive test", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 60 minutes and up to 120 minutes post treatment administration"
            }, 
            {
                "description": "For the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Mean values of valid reaction time to visual and auditory tests were calculated.", 
                "measure": "Change from baseline in mean time of accurate responses to DAT Cognitive test", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 60 minutes and up to 120 minutes post treatment administration"
            }, 
            {
                "description": "For the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Mean values of incorrect and missed responses to visual and auditory tests were calculated.", 
                "measure": "Change from baseline in number of incorrect and missed responses to DAT Cognitive test", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 60 minutes and up to 120 minutes post treatment administration"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}